Skin Treatment (Pharmacies) - Switzerland

Revenue in the Skin Treatment market is projected to reach US$107.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.91%, resulting in a market volume of US$136.40m by 2029.
In global comparison, most revenue will be generated United States (US$3.32bn in 2024).
In relation to total population figures, per person revenues of US$12.12 are generated in 2024.

Definition: Skin Treatment Market
The Skin Treatment market encompasses a range of over-the-counter (OTC) natural and synthetic medical products designed for skin treatment. This category includes antibacterial preparations, agents for acne treatment, and antifungal solutions. These treatment preparations are available in various forms, such as ointments, creams, gels, pills, capsules, washing lotions, peelings, pastes, solutions, fluids, suppositories, and sprays. Both external and internal applications are covered in this market segment. It's important to note that prescription medications, products contravening state regulations, items that do not explicitly serve as skin treatment drugs (e.g., painkillers), or those primarily intended for cosmetic purposes are excluded from this definition. This market exclusively covers product sales through pharmacies.

Additional Information:
The Skin Treatment market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Agents for internal and external application
Preparations to treat skin diseases (e.g. acne treatment)

Prescription medicines
Homeopathic remedies
Painkillers
Cosmetic products
Adhesive patches

The Skin Treatment (Pharmacies) market in Switzerland has witnessed significant growth in recent years, driven by changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Skin Treatment (Pharmacies) market in Switzerland have shifted towards natural and organic products. Consumers are increasingly conscious of the ingredients used in skincare products and are opting for those that are free from harmful chemicals. This preference for natural and organic products is driven by a growing awareness of the potential health risks associated with synthetic ingredients. Additionally, Swiss consumers are known for their high standards when it comes to quality and efficacy, leading them to seek out products that deliver visible results. Trends in the Skin Treatment (Pharmacies) market in Switzerland reflect the global demand for anti-aging products. With an aging population and a desire to maintain a youthful appearance, Swiss consumers are investing in products that target wrinkles, fine lines, and other signs of aging. This trend is further fueled by advancements in skincare technology, which have led to the development of innovative products that claim to rejuvenate the skin and promote a more youthful complexion. Local special circumstances also play a role in the development of the Skin Treatment (Pharmacies) market in Switzerland. The country is known for its high standard of living and disposable income, which allows consumers to spend more on skincare products. Furthermore, Switzerland has a strong pharmaceutical industry, with a reputation for producing high-quality and reliable products. This reputation extends to the skincare sector, where Swiss-made products are highly regarded for their quality and effectiveness. Underlying macroeconomic factors, such as a stable economy and a strong healthcare system, contribute to the growth of the Skin Treatment (Pharmacies) market in Switzerland. The country's robust economy provides consumers with the financial means to invest in skincare products, while its healthcare system ensures access to a wide range of products and treatments. Additionally, Switzerland's reputation for precision and innovation in the healthcare industry attracts international skincare brands, further driving market growth. Overall, the Skin Treatment (Pharmacies) market in Switzerland is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize natural and organic products, seek anti-aging solutions, and benefit from a strong economy and healthcare system, the market is expected to continue its upward trajectory.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.